drugset / Trial / NCT01322360

Safety and Pharmacokinetic Study of Oral Morphine Sulfate in Pediatric Subjects

NCT01322360

Phase 4 Completed 50 enrolled Roxane Laboratories
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the tolerability and safety of oral morphine sulfate in the treatment of postoperative pain in different pediatric age groups following multiple-dose administration. To determine multiple-dose pharmacokinetics (PK) of morphine sulfate in pediatric subjects. To compare plasma concentration of morphine sulfate in each age group of pediatric subjects with adult plasma morphine sulfate concentrations.

Timeline

Start
2011-04
Primary completion
2012-04
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Morphine Other / unclassified 10 mg Oral
Subject Morphine Other / unclassified 15 mg Oral
Subject Morphine Other / unclassified 20 mg Oral
Subject Morphine Other / unclassified 30 mg Oral

Indications

No indication recorded.